Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Imipenem”

65 trials

Showing 20 of 65 results

Early research (Phase 1)Study completedNCT04802863
What this trial is testing

Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

Who this might be right for
Bacterial Infections
Evopoint Biosciences Inc. 21
Post-approval studies (Phase 4)Study completedNCT01721408
What this trial is testing

Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

Who this might be right for
Intra-abdominal Infection
Pfizer 470
Large-scale testing (Phase 3)Study completedNCT03583333
What this trial is testing

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia
Merck Sharp & Dohme LLC 274
Not applicableStudy completedNCT00443885
What this trial is testing

Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC

Who this might be right for
Gram Negative Organism
University of Pittsburgh 500
Post-approval studies (Phase 4)Study completedNCT02897206
What this trial is testing

Imipenem Prophylaxis in Patients With Acute Pancreatitis

Who this might be right for
Acute Pancreatitis
University Hospital Rijeka 98
Large-scale testing (Phase 3)Study completedNCT00081744
What this trial is testing

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Who this might be right for
Gram-Positive Bacterial InfectionsCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 850
Early research (Phase 1)Study completedNCT04493151
What this trial is testing

Imipenem/Cilastatin/Relebactam PK in ECMO

Who this might be right for
Sepsis
Joseph L. Kuti, PharmD 8
Large-scale testing (Phase 3)Study completedNCT03969901
What this trial is testing

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

Who this might be right for
Suspected or Documented Gram-negative Bacterial Infection
Merck Sharp & Dohme LLC 115
Testing effectiveness (Phase 2)Ended earlyNCT00707239
What this trial is testing

Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia

Who this might be right for
Pneumonia, Bacterial
Pfizer 108
Post-approval studies (Phase 4)UnknownNCT02616354
What this trial is testing

Preliminary Research On Two-step Dosing Of Imipenem/Cilastatin

Who this might be right for
Sepsis
Southeast University, China 24
Post-approval studies (Phase 4)Study completedNCT02213783
What this trial is testing

Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia

Who this might be right for
Patients With Febrile Neutropenia
Prince of Songkla University 12
Early research (Phase 1)Study completedNCT04482569
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin

Who this might be right for
Bacterial Infections
Evopoint Biosciences Inc. 88
Large-scale testing (Phase 3)Study completedNCT02452047
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)

Who this might be right for
Bacterial Infections
Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)Ended earlyNCT01381549
What this trial is testing

GSK2251052 in Complicated Urinary Tract Infection

Who this might be right for
Infections, Urinary Tract
GlaxoSmithKline 20
Post-approval studies (Phase 4)Study completedNCT01379157
What this trial is testing

Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia

Who this might be right for
Ventilator Associated Pneumonia
Prince of Songkla University 8
Not applicableStudy completedNCT01852630
What this trial is testing

Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure

Who this might be right for
Spontaneous Bacterial Peritonitis
Institute of Liver and Biliary Sciences, India 175
Testing effectiveness (Phase 2)Study completedNCT01506271
What this trial is testing

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Who this might be right for
Intra-abdominal Infections
Merck Sharp & Dohme LLC 351
Early research (Phase 1)Study completedNCT04147221
What this trial is testing

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

Who this might be right for
Sepsis
Hartford Hospital 9
Testing effectiveness (Phase 2)Study completedNCT02321800
What this trial is testing

Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Who this might be right for
Urinary Tract Infections
Shionogi 452
Post-approval studies (Phase 4)UnknownNCT01297842
What this trial is testing

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Who this might be right for
Drug Safety
Mahidol University 100
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation